Why the Incannex (ASX:IHL) share price is soaring 13%

The Incannex share price is soaring today as the company mulls a US listing. We take a closer look at its release.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Incannex Healthcare Ltd (ASX: IHL) share price is soaring today as the company announced that it is mulling a US listing. Shares in the small-cap health care stock are currently trading 12.82% higher as a result. This has held Incannex shares to rise to a price of 22 cents.

Why is the Incannex share price flying?

Today the Incannex share price is trading strongly higher. This comes as the company announced that it is intending to list on the US market. The company has executed a binding consulting agreement with EAS Advisors to facilitate the listing.

Incannex noted that the predominant purpose of the arrangement was for EAS to introduce it to US banks and institutions. With the aim of dual listing the company on either the Nasdaq Composite (INDEXNASDAQ: .IXIC) or the NYSE Composite (INDEXNYSEGIS: NYA). While also retaining its listing on the ASX.

It is worth noting that the term of the agreement is 12 months. EAS will be paid both with Incannex options and a standard retainer. The advisory firm is also going to assist with financial modelling, presentation preparation, and external data room maintenance. This will be on top of generating global investor awareness.

Management Comments

CEO and Managing Director of Incannex Healthcare, Joel Latham, welcomed the news by saying:

After several months of getting to know one another, Eddie and EAS have joined our broader team to evaluate opportunities to list IHL securities in the United States on one of the main markets. We have made this decision because of deep investor interest and corporate activity in both cannabinoid-based pharmaceuticals and psychedelic therapeutic endeavours in North America. We're delighted to be working with the team at EAS, which has an excellent track record of growing international awareness for ASX companies.

About the Incannex share price

The Incannex share price has performed well as of late as it recently released positive drug results.

In the last month alone, its shares are up a whopping 37.5%, easily outpacing the All Ordinaries Index (ASX: XAO). Incannex is currently valued at $229.24 million.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man looks down with fright as he falls towards the ground.
Broker Notes

Down 9% this week, are CBA shares entering 'a major correction cycle'?

After this week's historic share price crash, what’s next for CBA shares?

Read more »

man thinking about whether to invest in bitcoin
Broker Notes

Buy, hold, sell: CBA, CSL, and Life360 shares

Do analysts rate these popular shares as buys? Let's find out.

Read more »

A woman wearing green flexes her bicep.
Share Market News

These ASX dividend shares could power your retirement income

This mix delivers income, stability and long-term cash flow growth.

Read more »

Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.
Dividend Investing

CGT tax changes may encourage investors into ASX dividend shares: Expert

Yield may become more important to some investors than growth, says this expert.

Read more »

Five happy young friends on the coast, dabbing and raising their arms in the air.
Share Market News

4 ASX 200 shares tipped to climb 75% to 126% higher

Find out which ASX 200 shares I have my eye on right now.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: GrainCorp, Treasury Wine, and Xero shares

What is Morgans saying about these popular shares this month?

Read more »

A man with a wide, eager smile on his face holds up three fingers.
Broker Notes

Brokers name 3 ASX shares to buy right now

Which shares are top brokers feeling bullish about this week?

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors ended the trading week on a sour note.

Read more »